Taken together, these results suggested that NCL-Orai1 interaction-meditated calcium entry was crucial for breast cancer development, and blocking the NCL-Orai1 pathway may be an effective strategy for the treatment of some breast cancer subtypes. The gene discussed is NUCLEOLIN; the disease is breast carcinoma.